Ethanol is humanity’s second-favorite psychoactive drug
Only caffeine outranks alcohol worldwide. Natufian beer goes back at least 13,000 years, global beverage sales topped US$1.5 trillion in 2017, and ethanol still acts as a brain depressant that can feel stimulating in small doses.
Alcohol’s active ingredient is ethanol, the CNS depressant in beer, wine, and spirits. It dampens neuronal firing and can bring euphoria, less anxiety, more sociability, sedation, and impaired thinking, memory, motor skill, and sensation. At low doses the feel can be stimulant-like; once blood alcohol content climbs past about one gram per liter, depression deepens toward stupor and, at extremes, death. Humans have chased those effects for millennia—the earliest known beer is tied to Natufian culture in the Middle East some 13,000 years ago—and alcohol remains legal and socially ordinary in most countries, unlike many other recreational drugs.
The public-health ledger is heavy. Short-term costs include foggy cognition, dizziness, nausea, vomiting, and hangover. Long-term use links to liver disease, hepatitis, cardiomyopathy, neuropathy, brain damage including dementia syndromes, and cancers; alcohol and metabolites such as acetaldehyde sit in IARC group 1. The World Health Organization advises there is no safe consumption level. Ethanol is also a teratogen: CDC guidance ties drinking by women who are pregnant or trying to become pregnant to fetal alcohol spectrum disorders and recommends abstinence in those settings. Empty calories matter too—USDA counts about 6.93 kilocalories per gram—and a standard 44 mL US spirit pour at 40 percent ethanol delivers roughly 14 grams and 98 calories without essential nutrients.
Paradoxes sit beside the harms. When fomepizole is unavailable, ethanol can compete for alcohol dehydrogenase and slow formation of toxic metabolites from methanol or ethylene glycol poisoning. People use drink as liquid courage in military history, as a pain or social-anxiety self-medication—often worsening anxiety or depression with long excess—and as a social lubricant; one UK study associated regular moderate drinking with happiness and life satisfaction, especially around community pubs. None of that cancels carcinogenicity, addiction risk, or WHO’s no-safe-level stance. The molecule is ancient, profitable, and pharmacologically double-edged.
Source: Alcohol (drug)
